Search Results

Deals

AMETEK Completes Acquisition of Paragon Medical

AMETEK, Inc. (NYSE: AME) today announced that it has completed its acquisition of Paragon Medical, a leading provider of highly engineered medical components and instruments, from affiliates of American Securities LLC, in an all-cash transaction valued at approximately $1.9 billion.

December 8, 2023

·

1 min read

Business

Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance

Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2024, and reaffirmed its 2024 net revenue guidance.

May 8, 2024

·

12 min read

BioMidwest

Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference

Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024, at 5:00 p.m. Pacific Time / 6:00 p.m. Mountain Time.

May 2, 2024

·

1 min read

Deals

Elevance Health Announces Closing of Paragon Healthcare Acquisition

Elevance Health announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

March 11, 2024

·

6 min read

Deals

AMETEK Announces Agreement to Acquire Paragon Medical

AMETEK, Inc. announced that it has entered into a definitive agreement to acquire Paragon Medical, a leading provider of highly engineered medical components and instruments, from affiliates of American Securities LLC in an all-cash transaction valued at approximately $1.9 billion.

October 31, 2023

·

1 min read

Deals

Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases

Paragon Therapeutics announced today that the third company founded based on assets generated by Paragon, Oruka Therapeutics (“Oruka”), has entered into a definitive agreement with ARCA biopharma to combine the companies in an all-stock transaction.

April 3, 2024

·

3 min read

Deals

Elevance Health to Acquire Paragon Healthcare

Elevance Health announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

January 4, 2024

·

7 min read

Business

Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024

Paragon 28, Inc. announced that Stephen Deitsch, Chief Financial Officer, has notified the Company of his intent to pursue an opportunity with OrganOx Limited, a commercial stage UK-based medical device company focused on therapeutic applications of isolated organ perfusion.

April 4, 2024

·

7 min read

Business

Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance

Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter and year ended December 31, 2023 and provided 2024 Net Revenue guidance.

February 29, 2024

·

15 min read

BioMidwest

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System

Paragon 28, Inc., is pleased to announce the launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains.

March 28, 2024

·

5 min read